Also, there was a significant association of decreased FUBP3 expression with increased bone marrow fibrosis which is a central pathological feature in the monitoring of leukaemias, with progressive fibrosis being an indicator of adverse outcomes in CML patients.49 The gene discussed is FUBP3; the disease is leukemia.